N.n. Alexandrov National Cancer Centre

This study is for people with advanced ovarian, fallopian tube, or primary peritoneal cancer that has a specific genetic feature (HRD). The trial tests whether taking a combination of two drugs (a PARP inhibitor and an angiogenesis inhibitor) after initial treatment can help keep…

This study tests a combination of immunotherapy drugs (PD-1/PD-L1 inhibitors) with chemotherapy, with or without another drug called bevacizumab, in 120 adults with cervical cancer that has spread, persisted, or returned. The goal is to see if this approach helps patients live lo…

This study looks at men with prostate cancer that has not spread. During surgery to remove the prostate, doctors will either remove few or many nearby lymph nodes. The goal is to see which approach helps prevent the cancer from coming back in other parts of the body. About 800 me…

This study tests a lower-cost, academic version of CAR-T cell therapy for adults with relapsed or refractory large B-cell lymphoma. The treatment uses the patient's own immune cells, modified to target cancer cells. The goal is to see if this more affordable approach is safe and …